Indian Council of Medical Research (ICMR) has recently revised the treatment protocol for clinical management of Covid-19 patients.
“We will soon put up details on the (ICMR’s) website on Thursday,” said ICMR director-general, Dr Bhargava.
ICMR, the country’s apex health research institution, has been mulling over the use of Remdesivir, an antiviral drug that has shown improvement in coronavirus patients in formal clinical trials.
